Current & Former Smokers Needed for Lung Research Study Request More Information Trial Objective Our researchers are studying the lungs of current and former smokers to understand how to improve the diagnosis and treatment of Chronic Obstructive Pulmonary Disease (COPD), a disease that is common among smokers. You do not need to have COPD to participate in this study. To qualify, a candidate must be part of a Lung Cancer Screening program or be willing to have a lung cancer screening CT. Study participation involves: A 1-2 hour visit (can be scheduled immediately after your CT if there is space available) Questionnaires Collection of vital signs Breathing test (spirometry) Blood draw Enrollment New enrollment for this trial is temporarily paused Who Can Participate We are seeking people age 55-77 who: Are a current smoker or have quit within the past 15 years Have smoked a pack a day for 30 years Age: 55-77 Gender: Any Gender Estimated Time Commitment 1-2 hour visit (can be scheduled immediately after your CT if there is space available) × Payments are intended to compensate the participant for their time and effort during the study. Payments are typically given to the participant at the end of each completed study visit. Reimbursements are intended to compensate the participant for travel-related expenses. They must be approved by the study staff and require you to turn in receipts. Travel reimbursement will vary from study to study. Payment & Reimbursement Payment: Provided Travel Reimbursement: Not Available Trial Contact For more information, contact: Sara Cummings 303.398.1485 Request More Information Trial Location National Jewish Main Campus, Denver, CO Trial Sponsors COPD Foundation Principal Investigators James Finigan, MD + × James Finigan, MD Director, The Respiratory Centers of Excellence Medical Director, Lung Cancer Screening Program Professor Division of Pulmonary, Critical Care & Sleep Medicine Division of Oncology, Cancer Center Department of Medicine View Full Profile Make an Appoinment Request More Information Due to concerns around COVID-19 and our focus on helping to meet this momentous challenge, we have temporarily paused enrollment for this trial.